Thirteen-year follow-up of a mandibular implant-supported fixed complete denture in a patient with Sjogren's syndrome: A clinical report

https://doi.org/10.1016/j.prosdent.2005.09.010Get rights and content

This clinical report describes the treatment and long-term follow-up of a patient with Sjogren's syndrome treated with osseointegrated implants and a mandibular fixed complete denture. The implants and prosthesis have remained stable and functional for 13 years. Implant treatment may, therefore, offer a viable long-term treatment alternative for patients with Sjogren's syndrome.

Section snippets

Clinical report

The patient, a 67-year-old white man, had extensive fixed prosthodontic treatment of the mandibular arch that failed within 5 years of placement due to cervical caries. In retrospect, this may have been the first indication of the effects of xerostomia. The previous treating dentist then recommended coronal reduction, endodontic treatment of the retained roots, silver amalgam coronal restorations, and 2 intraradicular attachments (Zest Anchors, Escondido, Calif) to retain an overdenture. This

Summary

Over the course of 13 years, treatment of a man with SS has been documented. The treatment has been successful and without adverse effects. The patient reported dramatic improvements in comfort, function, and esthetics immediately after treatment and continues to report satisfaction with the treatment received. Based on the long-term favorable results experienced by this patient, other patients with SS and severe dry mouth may benefit from the placement of implant-supported prostheses. The

References (16)

  • R. Adell et al.

    A 15-year study of osseointegrated implants in the treatment of the edentulous jaw

    Int J Oral Surg

    (1981)
  • A.G. Payne et al.

    Implant-supported prostheses in patients with Sjogren's syndrome: a clinical report on three patients

    Int J Oral Maxillofac Implants

    (1997)
  • F. Isidor et al.

    Outcome of treatment with implant-retained dental prostheses in patients with Sjogren Syndrome

    Int J Oral Maxillofac Implants

    (1999)
  • P.P. Binon et al.

    Implant-supported fixed prosthesis treatment of a patient with Sjogren's syndrome: a clinical report

    Int J Oral Maxillofac Implants

    (1993)
  • H.M. Moutsopoulos et al.

    Sjogren's syndrome

  • H.M. Moutsopoulos

    Sjogren's syndrome

  • M.C. Hockberg

    Sjogren's syndrome

  • N. Delaleu et al.

    Sjogren's syndrome

    Euro J Oral Sci

    (2005)
There are more references available in the full text version of this article.

Cited by (30)

  • Dental implants in patients suffering from autoimmune diseases: A systematic critical review

    2022, Journal of Stomatology, Oral and Maxillofacial Surgery
    Citation Excerpt :

    Of all the autoimmune diseases reviewed, most were on patients with SS. Overall, with the exception of one study, data showed an overall survival rate similar to that reported for the general population [17–33]. However, two specific peculiarities related to SS patients receiving implants emerged [19,21,23,27,29].

  • Dental implants in patients with Sjögren's syndrome: a case series and a systematic review

    2019, International Journal of Oral and Maxillofacial Surgery
    Citation Excerpt :

    At the end of the process, assessment of the full-text reports of the remaining 20 articles led to the exclusion of two publications10,11. One of these was excluded because the clinical case was later reported in another publication4, but with follow-up information. In the second excluded article, the same cases were reported in another published study by the same research group12.

  • Dental implants in the medically compromised patient

    2013, Journal of Dentistry
    Citation Excerpt :

    Theoretically DI may help prosthesis retention in patients with dry mouth (hyposalivation). Although cases with hyposalivation have been successfully managed with DI98,99 and even 7 out of 8 patients with Sjögren syndrome improved their oral comfort levels with implant-retained prostheses,100 there are no systematic studies evaluating the outcomes of DI therapy in these patients (Table 1). A retrospective study on patients suffering from rheumatic disorders such as rheumatoid arthritis and other connective tissue diseases and compromised salivary flow showed high implant survival rates (cumulative 3-year implant success rate of 96.1%).

View all citing articles on Scopus
View full text